发明名称 STABILIZED SUSTAINED RELEASE TRAMADOL FORMULATIONS
摘要 A stabilized sustained release oral solid dosage form which includes an effective amount of tramadol or a pharmaceutically acceptable salt thereof dispersed in a matrix of a hydrophobic material comprising a wax-like substance which was melted or softened during the preparation of the matrix, is cured at a temperature from about 35 DEG C to about 65 DEG C for a time period from about 4 to about 72 hours, such that the formulation, when subjected to in vitro dissolution after exposure to accelerated storage conditions of at least one month at 40 DEG C/75 % RH, releases an amount of tramadol which does not vary at any given dissolution time point by more than about 20 % of the total amount of tramadol released when compared to in vitro dissolution conducted prior to subjecting the dosage form to the accelerated storage conditions.
申请公布号 WO9901111(A1) 申请公布日期 1999.01.14
申请号 WO1998US14087 申请日期 1998.07.02
申请人 EURO-CELTIQUE, S.A.;OSHLACK, BENJAMIN;HUANG, HUA-PIN;CHASIN, MARK;GOLDENHEIM, PAUL 发明人 OSHLACK, BENJAMIN;HUANG, HUA-PIN;CHASIN, MARK;GOLDENHEIM, PAUL
分类号 A61K9/20;A61K9/22;A61K9/26;A61K9/42;A61K31/135;A61K31/137;A61K47/06;A61K47/10;A61K47/12;A61K47/14;A61K47/30;A61K47/32;A61K47/38;A61K47/44;A61P25/02;A61P29/00;(IPC1-7):A61K9/22 主分类号 A61K9/20
代理机构 代理人
主权项
地址